sign in sign up
<<
Home , Diabetes insipidus, Endocrinology, Pregnanetriol, Pregnanetriolone, Thyroglobulin

For Endocrinologists

Endocrinology Test List Test List

Extensive Capabilities Managing patients with endocrine disorders is complex. Having access to the right test for the right patient is key. With a legacy of expertise in endocrine laboratory diagnostics, Quest Diagnostics offers an extensive menu of laboratory tests across the spectrum of endocrine disorders.

This test list highlights the extensive menu of laboratory diagnostic tests we offer, including highly specialized tests and those performed using highly specific and sensitive mass spectrometry detection. It is conveniently organized by glandular function or common endocrine disorder, making it easy for you to identify the tests you need to care for the patients you treat. Comprehensive Care Quest Diagnostics Nichols Institute has been pioneering state-of-the-art endocrine testing for over four decades. Our commitment to innovative diagnostics and our dedication to quality and service means we deliver solutions that enable you to make informed clinical decisions for comprehensive patient management. We strive to remain at the forefront of innovation in endocrine testing so you can deliver the highest level of patient care.

Abbreviations and Footnotes NDM, neonatal mellitus; MODY, maturity-onset diabetes of the young; CH, congenital ; MSUD, maple syrup ; IHH, idiopathic hypogonadotropic ; BBS, Bardet-Biedl syndrome; OI, osteogenesis imperfecta; PKD, polycystic disease; OPPG, -pseudoglioma syndrome; CPHD, combined pituitary deficiency; GHD, deficiency.

The tests highlighted in green are performed using highly specific and sensitive mass spectrometry detection. Panels that include a test(s) performed using mass spectrometry are highlighted in yellow. For tests highlighted in blue, refer to the Athena Diagnostics website (athenadiagnostics.com/content/test-catalog) for test information. These tests are performed by Athena Diagnostics.

† Multiple test codes are available. Refer to the Quest Diagnostics Nichols Institute Directory of Services or the online Test Center (QuestDiagnostics.com) for test information.

1 This test was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute. Performance characteristics refer to the analytical performance of the test.

2 This test was developed and its performance characteristics have been determined by Athena Diagnostics. Performance characteristics refer to the analytical performance of the test.

3 This test was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.

4 This test was performed using a kit that has not been cleared or approved by the FDA. The analytical performance characteristics of this test have been determined by Quest Diagnostics Nichols Institute. This test should not be used for diagnosis without confirmation by other medically established means.

Reflex tests are performed at an additional charge.

The following tests that are included in panels may be ordered separately: , alkaline phosphatase, ALT, AST, bilirubin (direct and total), creatinine (serum and urine), panel, hemoglobin, hepatic function panel, iron, phosphate, , and total . Quest Diagnostics – Endocrinology Test List Test Code Test Name Adrenal Medullary Function/ Congenital Adrenal Hyperplasia (CAH) Hemoglobin A1c with Calculated Mean Plasma 8181 1 (MPG) 39627(X) Catecholamines, Fractionated, 24-Hour Urine 14755(X) CAH (21-Hydroxylase Deficiency) Common Mutations Detects 11 CYP21A2 gene mutations and the 30kb deletion. 314(X) Catecholamines, Fractionated, Plasma 16802 Hemoglobin A1c with eAG 1 16072(X) CAH (21-Hydroxylase Deficiency) Rare Mutations 16715 Hemoglobin A1c with Reflex to GlycoMark® 5244 Catecholamines, Fractionated, Random Urine Includes sequencing of the entire CYP21A2 gene. 802 HNF4A (MODY1) DNA Sequencing and Deletion Test2 16381 Catecholamines, Fractionated, Supine, Plasma CAH Panel 1 (21-OH vs 11-βOH) 16382 Catecholamines, Fractionated, Upright, Plasma 15269(X) Includes 17-hydroxyprogesterone/11-deoxycortisol ratio, 37054(Z) β-Hydroxybutyrate 11-deoxycortisol/ ratio, , and total . 39626(X) Catecholamines, Fractionated, and VMA, 24-Hour Urine 36177(X) IA-2 CAH Panel 3 ( synthase deficiency) 1 16379 , Electrochemiluminescence1 15273(X) Includes 17-OH /11-deoxycortisol ratio, and 36590 IGF Binding Protein-1 (IGFBP-1) 18-hydroxycorticosterone/aldosterone ratio. 2 39527(X) , 24-Hour Urine 853 INS (NDM) DNA Sequencing Test CAH Panel 4 (17-OH deficiency in females) 561 6346 Homovanillic Acid, Random Urine 15274(X) Includes progesterone/17-hydroxyprogesterone ratio, , cortisol, aldosterone, and . 19548 Metanephrines, Fractionated, Free, LC/MS/MS, Plasma 36178 Insulin 15276(X) CAH Panel 6 (StAR deficiency) 36700 Insulin, Free (Bioactive) 14962(X) Metanephrines, Fractionated, LC/MS/MS, 24-Hour Urine Includes cortisol, , DHEA, and aldosterone. 91083 Insulin, LC/MS/MS 14961(X) Metanephrines, Fractionated, LC/MS/MS, Random Urine CAH Panel 6C (Full Screen) 834 IPF1 (MODY4) DNA Sequencing Test2 Evaluation2 16978 Includes androstenedione, cortisol, 11-deoxycortisol, DHEA, 889 17-hydroxypregnenolone, 17-hydroxyprogesterone, progesterone, and 2 Detects mutations in RET, SDHB, and VHL. total testosterone. 841 IPF1 (NDM) DNA Sequencing Test 39517(X) VMA (), 24-Hour Urine 36741 Islet Cell Antibody Screen with Reflex to Titer2 15277(X) CAH Panel 7 ( replacement monitoring) 1710 VMA (Vanillylmandelic Acid), Random Urine Includes androstenedione, total testosterone, 17-hydroxyprogesterone. 843 KCNJ11 (NDM) DNA Sequencing Test2 Adrenocortical Function See below for congenital adrenal hyperplasia. CAH Panel 8 (17-OH deficiency in males) and Glucose Control Including Insulin 15279(X) Includes progesterone/17-hydroxyprogesterone ratio, corticosterone, 2 91398 Includes , total and HDL; glucose; insulin, LC/MS/MS; 815 ABCD1 () DNA Sequencing Test cortisol, aldosterone, and total testosterone. triglycerides; and calculated components. 211 ACTH, Plasma CAH Panel 9 (3β-HSD deficiency) 15281 Microalbumin, 24-Hour Urine (with Creatinine) 15280(X) Includes 17-hydroxypregnenolone/17-hydroxyprogesterone ratio, 4645 Adrenal Antibody Screen with Reflex to Titer DHEA/androstenedione ratio, and cortisol. 4555 Microalbumin, 24-Hour Urine (without Creatinine) 19552(X) Aldosterone, 24-Hour Urine CAH Panel 11, Neonatal Random Urine 6517 Microalbumin, Random Urine (with Creatinine) 229 Includes 17-OH ; 15, 17-(OH)2-pregnanolone; 16-OH 17674 Microalbumin, Random Urine (without Creatinine) 17181 Aldosterone, LC/MS/MS 10046(X) DHEA; ; tetrahydro 11-deoxycortisol; ; 16- OH pregnenolone; pregnenetriol; ; 6-OH tetrahydro Monogenic Diabetes (MODY) Evaluation2 † Aldosterone/Cortisol Ratio 11-deoxycortisol; tetrahydro 11-dehydrocorticosterone; A-cortolone; 885 Includes sequencing and deletion detection in GCK, HNF4A, TCF1, B-cortolone; and 6-OH tetrahydro 11-dehydrocorticosterone. and TCF2 and sequencing of IPF1. † Aldosterone/Cortisol Ratio, Adrenal Vein Sampling Congenital Adrenal Hyperplasia (CAH) Evaluation2 2 882 Mellitus Evaluation 16845 Aldosterone/Plasma Renin Activity Ratio, LC/MS/MS 879 Includes sequencing and deletion detection in CYP21A2 and Detects mutations in ABCC8, GCK, INS, IPF1, and KCNJ11. sequencing of CYP11B1. 5276(X) 3α-Androstanediol Glucuronide (3-Alpha Diol G) 678 Osmolality, Random Urine 875 CYP11B1 (CAH) DNA Sequencing Test2 17182 Androstenedione, LC/MS/MS 677 Osmolality, Serum 877 CYP17A1 DNA Sequencing Test2 6547(X) Corticosterone, LC/MS/MS 760(X) Proinsulin4 CYP21A2 (CAH) DNA Evaluation2 37371 Cortisol Binding () 880 Includes sequencing of the entire CYP21A2 gene, as well as detection of 34480 Somatostatin1 the common 30kb deletion. 37355(X) Cortisol, Free and , 24-Hour Urine 804 TCF1 (MODY3) DNA Sequencing and Deletion Test2 30543 11-Deoxycortisol, LC/MS/MS, Serum 37077(X) Cortisol, Free and Total, LC/MS/MS 805 TCF2 (MODY5) DNA Sequencing and Deletion Test2 878 HSD3B2 DNA Sequencing Test2 36423(X) Cortisol, Free, LC/MS/MS Dynamic Testing 17180 17-Hydroxyprogesterone, LC/MS/MS 11280(X) Cortisol, Free, LC/MS/MS, 24-Hour Urine 17832(X) Aldosterone, Response to ACTH Stimulation, LC/MS/MS 17654(X) 17-Hydroxyprogesterone, Neonatal/Infant 90582 Cortisol, Free, LC/MS/MS, Second Void Urine Androstenedione Response to ACTH Stimulation, 2 19511(X) 19897(X) Cortisol, LC/MS/MS, Saliva Lipoid CAH (StAR) Evaluation LC/MS/MS 874 Detects mutations (including point mutations, deletions, insertions, and 11281(X) Cortisol, Total, LC/MS/MS rearrangements) in StAR. 10068(X) Catecholamines, Total, Suppression by Clonidine, Plasma 37554(X) Cortisone, 24-Hour Urine 738 Pregnanetriol, Urine 16434 Cortisol, Free, Response to ACTH Stimulation 37098(X) Cortisone, Serum3 Steroid Panel, 21-Hydroxylase Deficiency/ 38149(X) Cortisol Response to ACTH Stimulation, Serum 90397 Differentiation 90973 Deoxycorticosterone Includes 17-hydroxyprogesterone, androstenedione, and cortisol. † C-Peptide Response to Glucose 30543 11-Deoxycortisol, LC/MS/MS, Serum Steroid Panel, Comprehensive 14747(X) C-Peptide Stimulation by Glucagon 29391(X) Dexamethasone Includes androstenedione, corticosterone, cortisol, cortisone, † Growth Hormone, Multiple Specimens 90392 deoxycorticosterone, 11-deoxycortisol, DHEA, 18-hydroxycorticosterone, DHEA (), Unconjugated, 17-hydroxypregnenolone, 17-hydroxyprogesterone, pregnenolone, 17682(X) 17-Hydroxyprogesterone Response to ACTH Stimulation 19894 progesterone, and total testosterone. LC/MS/MS † Insulin Response to Glucose Steroid Panel, Congenital Adrenal Hyperplasia (CAH) 38954 DHEA (Dehydroepiandrosterone), Urine † Proinsulin Response to Glucose4 90398 Includes androstenedione, cortisol, deoxycorticosterone, 402 DHEA Sulfate 11-deoxycortisol, DHEA, 17-hydroxypregnenolone, 17-hydroxyprogesterone, progesterone, and total testosterone. Endocrine Autoimmunity 36168 , Free, Serum1 Steroid Panel, PCOS/CAH Differentiation 4645 Adrenal Antibody with Reflex to Titer 1 90567 Dihydrotestosterone, LC/MS/MS 90426 Includes androstenedione, 11-deoxycortisol, DHEA, 2 17-hydroxyprogesterone, and free and total testosterone. Autoimmune Polyglandular Syndrome (AIRE) Evaluation Panel 2 812 Detects point mutations, deletions, insertions, and rearrangements 36707(X) Includes androstenedione, DHEA sulfate, and free and total testosterone. Diabetes Mellitus, Types 1 and 2 in AIRE. 15202 17-Hydroxycorticosteroids with Creatinine, 24-Hour Urine 876 ABCC8 (NDM) DNA Sequencing Test2 15114 Gastric Parietal Cell Antibody, ELISA 11178(X) 18-Hydroxycortisol, Free, 24-Hour Urine 15060(X) Adiponectin4 34878 Glutamic Acid Decarboxylase-65 Antibody 38071(X) 6 Beta-Hydroxycortisol, 24-Hour Urine 837 CEL (MODY8) Mutation Analysis2 37072(X) Growth Hormone Antibody3 37916(X) 21-Hydroxylase Antibody 372 C-Peptide 37916(X) 21-Hydroxylase Antibody 8352 17-Hydroxypregnenolone, LC/MS/MS 4643(X) C-Peptide, 24-Hour Urine 36177(X) IA-2 Antibody 17180 17-Hydroxyprogesterone, LC/MS/MS Diabetes, Advancing Chronic 36178 Insulin Autoantibody 17654(X) 17-Hydroxyprogesterone, Neonatal/Infant Management Panel 36741 Islet Cell Antibody Screen with Reflex to Titer3 91713(X) Includes electrolyte panel; microalbumin, random urine with creatinine; 15201(X) 17- with Creatinine, 24-Hour Urine creatinine, serum; hemoglobin; PTH, intact and ; phosphate 36578 PTH Antibody1 (as phosphorus); QuestAssureD™ 25-hydroxyvitamin D (D2, D3), 1 70184(X) 17-Ketosteroids, Fractionated, , Urine LC/MS/MS. 36574 T3 () Antibody 4932(X) 17-Ketosteroids, Fractionated, Urine Diabetes, Newly Diagnosed and Monitoring Panel 36576 T4 (Thyroxine) Antibody1 91712(X) Includes glucose; hemoglobin A1c; lipid panel; hepatic function panel; NR0B1 (Adrenal Hypoplasia Congenita) 5738 TBII (Thyrotropin-Binding Inhibitory Immunoglobulin) 814 microalbumin, random urine with creatinine; creatinine, serum. DNA Sequencing Test2 Diabetes Risk Assessment Panel 267 Thyroglobulin Antibody 16846 Plasma Renin Activity, LC/MS/MS Includes lipid panel (cholesterol, HDL, cholesterol/HDL ratio, 7260(X) Peroxidase and Thyroglobulin 91920 LDL-calculated, and triglycerides) with reflex to direct LDL, glucose, 738 Pregnanetriol, Urine and hemoglobin A1c. 5081 Antibody (Anti-TPO) 31493(X) Pregnenolone, LC/MS/MS 8340 Fructosamine 36577 TSH Antibody1 Primary Evaluation2 10584(X) GAD65, IA-2, and Insulin Autoantibody 30551 TSI (Thyroid Stimulating Immunoglobulin) 816 Detects mutations (including point mutations, deletions, insertions, and rearrangements) in ABCD1, AIRE, and NR0B1. 803 GCK (MODY2) DNA Sequencing and Deletion Test2 Endocrine 17183 Progesterone, LC/MS/MS 842 GCK (NDM) DNA Sequencing Test2 827 ABCC8 (CH) DNA Sequence Test2 30740 Binding Globulin 519 Glucagon1 815 ABCD1 (Adrenoleukodystrophy) DNA Sequencing Test2 14966 Testosterone, Free, Bioavailable, and Total, LC/MS/MS † Glucose 711 ACTN4 DNA Sequencing Test2 36170 Testosterone, Free (Dialysis) and Total (LC/MS/MS) 34878 Glutamic Acid Decarboxylase-65 Antibody 14531 Acylcarnitine, Plasma Testosterone, Total and Free and Sex Hormone 5032(X) Glycated Albumin 29881 Analysis, LC/MS, CSF 37073 Binding Globulin 29488(X) Glycohemoglobin, Total 767(X) Amino Acid Analysis, LC/MS, Plasma 15983 Testosterone, Total, LC/MS/MS 19599 GlycoMark® 36183 Amino Acid Analysis, LC/MS, Urine 39613(X) Tetrahydroaldosterone, Urine 496 Hemoglobin A1c 19779(X) Amino Acid Analysis for MSUD, LC/MS, Plasma

Liquid Chromatography Tandem Mass Spectrometry (LC/MS/MS) Athena Diagnostics test Panel includes LC/MS/MS test(s) Anosmic Kallmann/IHH Evaluation2 279 GnRHR DNA Sequencing Test2 16313 XSense®, Fragile X with Reflex1 462 Detects mutations in FGF8, FGFR1, GnRHR, KAL1, KISS1R, PROK2, and 2 PROKR2. Growth Hormone Deficiency Evaluation Endocrine Hypertension 848 Includes sequencing and deletion detection in SHOX and sequencing 893 ApoB Mutation Analysis2 of GH1 and GHRHR. 17181 Aldosterone, LC/MS/MS AQP2 (Nephrogenic ) DNA 775 HSD11B2 DNA Sequencing Test2 16845 Aldosterone/Plasma Renin Activity Ratio, LC/MS/MS 852 2 Sequencing Test Hypercholesterolemia Evaluation2 36718 Angiotensin II 2 895 Autoimmune Polyglandular Syndrome (AIRE) Evaluation Detects mutations in LDLR and disease-associated regions of ApoB. 39627(X) Catecholamines, Fractionated, 24-Hour Urine 812 Detects point mutations, deletions, insertions, and rearrangements 2 in AIRE. Hypophosphatemic Rickets Evaluation 857 Detects mutations in FGF23 and PHEX2. 11281(X) Cortisol, Total, LC/MS/MS 2 2 Bardet-Biedl Syndrome Evaluation 2 774 CYP11B1 DNA Sequencing Test 887 Detects mutations in BBS1, BBS2, and BBS10. 716 INF2 (FSGS) DNA Sequencing Test 779 CYP11B1/2 DNA Chimeric Gene Fusion Test2 871 BBS1 (BBS) DNA Sequencing Test2 Inherited Focal and Segmental (FSGS) 717 Evaluation2 881 Endocrine Hypertension (HSD11B2) Evaluation2 872 BBS2 (BBS) DNA Sequencing Test2 Detects mutations in ACTN4, INF2, NPHS2, and TRPC6. 775 HSD11B2 DNA Sequencing Test2 886 BBS10 (BBS) DNA Sequencing Test2 173 KAL1 DNA Sequencing Test2 11178(X) 18-Hydroxycortisol, Free, 24-Hour Urine CAH (21-Hydroxylase Deficiency) Common Mutations1 826 KCNJ11 (CH) DNA Sequencing Test2 14755(X) Detects 11 CYP21A2 gene mutations and the 30kb deletion. Liddle's Syndrome Evaluation2 364 KISS1R DNA Sequencing Test2 747 Detects mutations in SCNN1B and SCNN1G. CAH (21-Hydroxylase Deficiency) Rare Mutations1 2 16072(X) Includes sequencing of the entire CYP21A2 gene. 664 KRAS DNA Sequencing Test 14962(X) Metanephrines, Fractionated, LC/MS/MS, 24-Hour Urine 90649 Cardio IQ™ ApoE Genotype1 658 KRAS/RAF1/SOS1 DNA Sequencing Evaluation2 Monogenic Hypertension Evaluation2 749 Detects mutations in CYP11B1, HSD11B2, SCNN1B, and SCNN1G. 70107(X) Carnitine, LC/MS/MS 714 LAMB2 DNA Sequencing Test2 2 Pheochromocytoma Evaluation 15948(X) Carnitine, LC/MS/MS and Acylcarnitine 894 LDLR (Hypercholesterolemia) DNA Sequencing Test Includes total catecholamines, /creatinine ratio, total 10520 metanephrines, metanephrine/creatinine ratio, and creatinine (24-hour 2 Liddle's Syndrome Evaluation2 825 CASR DNA Sequencing Test urine). 747 Detects mutations in SCNN1B and SCNN1G. 2 461 CHD7 DNA Sequencing Test 2 LRP5 Idiopathic Osteoporosis (IOP) Type 1 Evaluation 748 Detects mutations in SCNN1A, SCNN1B, and SCNN1G. Chromosomal Microarray, Postnatal, 821 2 16478 DNA Sequencing Test ClariSure® Oligo-SNP1 772 SCNN1A DNA Sequencing Test2 811 LRP5 (OPPG) DNA Sequencing Test2 14596(X) Analysis, Blood 745 SCNN1B DNA Sequencing Test2 17625(X) Male Infertility Genetic Analysis 14595(X) Chromosome Analysis, High Resolution Fluid, , and Renal Function 817 Male (LHCGR) DNA Sequencing Test2 14597(X) Chromosome Analysis, Mosaicism 711 ACTN4 DNA Sequencing Test 818 MEN1 (MEN1) DNA Sequencing Test2 16843 Chromosome Analysis, Neonatal Blood 19552(X) 813 MEN2 (RET) DNA Sequencing Test2 Aldosterone, 24-Hour Urine 14593(X) Chromosome Analysis, 229 91002 Methylmalonic Acid, GC/MS/MS 861 COL1A1 (OI) DNA Sequencing Test2 17181 Aldosterone, LC/MS/MS 91032 Methylmalonic Acid, GC/MS/MS, Urine 862 COL1A2 (OI) DNA Sequencing Test2 † Aldosterone/Cortisol Ratio 2 749 Monogenic Hypertension Evaluation Combined Pituitary Hormone Deficiency Evaluation2 Detects mutations in CYP11B1, HSD11B2, SCNN1B, and SCNN1G. † Aldosterone/Cortisol Ratio, Adrenal Vein Sampling 865 Detects mutations in POU1F1 and PROP1. Nephrogenic Diabetes Insipidus (AVPR2) 16845 Aldosterone/Plasma Renin Activity Ratio, LC/MS/MS 2 851 Complete Kallmann/IHH Evaluation DNA Sequencing Test2 36718 Angiotensin II 679 Detects mutations in CHD7, FGF8, FGFR1, GnRHR, GnRH1, KAL1, KISS1R, 2 PROK2, PROKR2, and TACR3. 854 Nephrogenic Diabetes Insipidus Evaluation AQP2 (Nephrogenic Diabetes Insipidus) Includes DNA sequencing of AQP2 and AVPR2. 852 2 Complete PKD Evaluation2 DNA Sequencing Test 761 2 Detects mutations and deletions in PKD1 and PKD2. 721 Evaluation 252(X) Arginine (AVP, Hormone, ADH)3 2 Detects sequence variations in LAMB2, NPHS1, NPHS2, and WT1. 774 CYP11B1 DNA Sequencing Test Complete PKD Evaluation2 2 761 2 Neonatal Diabetes Mellitus Evaluation Detects mutations and deletions in PKD1 and PKD2. 779 CYP11B1/2 DNA Chimeric Gene Fusion Test 882 Detects mutations in ABCC8, GCK, INS, IPF1, and KCNJ11. CYP21A2 (CAH) DNA Evaluation2 2 6547(X) Corticosterone, LC/MS/MS 647 Neurofibromatosis Type 1 Deletion Test 880 Includes sequencing of the entire CYP21A2 gene, as well as detection of Detects deletions in NF1. 37371 Cortisol Binding Globulin (Transcortin) the common 30kb deletion. Neurofibromatosis Type 1 DNA Sequencing Test2 36423(X) Cortisol, Free, LC/MS/MS Cystic Fibrosis Complete Rare Mutation Analysis, Entire Gene 646 10917(X) Detects mutations in NF1. 1 11280(X) Cortisol, Free, LC/MS/MS, 24-Hour Urine Sequence 2 648 Neurofibromatosis Type 1 (NF1) Evaluation 16080(X) Cystic Fibrosis Gene Deletion or Duplication3 Detects deletions and mutations in NF1. 90582 Cortisol, Free, LC/MS/MS, Second Void Urine 10913(X) Cystic Fibrosis Rare Mutation Analysis, One Exon3 846 Noonan Syndrome (PTPN11) DNA Sequencing Test2 37355(X) Cortisol, Free and Cortisone, 24-Hour Urine 10915(X) Cystic Fibrosis Rare Mutation Analysis, Two Exon3 Normosmic Kallmann/IHH Evaluation2 37077(X) Cortisol, Free and Total, LC/MS/MS Detects mutations in FGFR1, GnRH1, GnRHR, KISS1R, PROK2, PROKR2, 1 667 10458(X) Cystic Fibrosis Screen and TACR3. 19897(X) Cortisol, LC/MS/MS, Saliva 10947(X) Cystine, 24-Hour Urine 710 NPHS2 (Podocin) Sequencing Analysis2 11281(X) Cortisol, Total, LC/MS/MS 401(X) Cystine, Quantitative, Random Urine 90404 Organic Acids, Qualitative, Urine 37554(X) Cortisone, 24-Hour Urine 3 Early Onset Evaluation2 90561 Organic Acids, Full Panel, Quantitative, Urine 37098(X) Cortisone, Serum 884 Detects mutations in LEPR and MC4R. Osteogenesis Imperfecta Evaluation2 10570(X) Cystatin C 883 Early Onset Obesity (LEPR) DNA Sequencing Test2 860 Detects mutations in COL1A1 and COL1A2. 90973 Deoxycorticosterone, LC/MS/MS Early Onset Obesity (MC4R) DNA Sequencing Test2 37356 Phenylalanine 640 Detects mutations in MC4R. 11178(X) 18-Hydroxycortisol, Free, 24-Hour Urine 26336(X) Phenylalanine and 2 881 Endocrine Hypertension (HSD11B2) Evaluation 716 INF2 (FSGS) DNA Sequencing Test 2 Pheochromocytoma Evaluation Inherited Focal and Segmental Glomerulosclerosis Familial Hypocalciuric Hypercalcemia (CASR) 889 Detects mutations in VHL, RET and SDHB. 829 2 DNA Sequencing Test 715 (FSGS) Evaluation 718 PLCE1 DNA Sequencing Test2 Detects mutations in ACTN4, NPHS2, and TRPC6. 195 FGF8 DNA Sequencing Test2 864 POU1F1 (CPHD) DNA Sequencing Test2 Inherited Focal and Segmental Glomerulosclerosis FGF23 (Hypophosphatemic Rickets) 717 (FSGS) Evaluation2 856 863 PROP1 (CPHD) DNA Sequencing Test2 DNA Sequencing Test2 Detects mutations in ACTN4, INF2, NPHS2, and TRPC6. PHEX (Hypophosphatemic Rickets) 2 196 FGFR1 DNA Sequencing Test2 855 714 LAMB2 DNA Sequencing Test DNA Sequencing Test2 14608(X) FISH, Angelman3 15281 Microalbumin, 24-Hour Urine (with Creatinine) Prader-Willi/Angelman Syndrome, FISH, Chromosome-Specific Probe (specify probe & 11369 3 4555 Microalbumin, 24-Hour Urine (without Creatinine) 37343(X) DNA Methylation Analysis chromosome number)3 175 PROK2 DNA Sequencing Test2 6517 Microalbumin, Random Urine (with Creatinine) 14610(X) FISH, DiGeorge, Velocardiofacial (VCFS)3 180 PROKR2 DNA Sequencing Test2 17674 Microalbumin, Random Urine (without Creatinine) 14615(X) FISH, Kallmann3 Pseudohypoaldosteronism Type 1 Evaluation2 Nephrogenic Diabetes Insipidus (AVPR2) 748 851 2 36053 FISH, Neonatal Screen3 Detects mutations in SCNN1A, SCNN1B, and SCNN1G. DNA Sequencing Test 14605(X) FISH, Prader Willi3 663 RAF1 DNA Sequencing Test2 Nephrogenic Diabetes Insipidus Evaluation2 854 Includes DNA sequencing of AQP2, and AVPR2. 14606(X) FISH, SRY/X Centromere3 772 SCNN1A DNA Sequencing Test2 Nephrotic Syndrome Evaluation2 2 14609(X) FISH, Williams3 745 SCNN1B DNA Sequencing Test 721 Detects sequence variations in LAMB2, NPHS1, NPHS2, and WT1. 14613(X) FISH, Wolf-Hirschhorn3 888 SDHB DNA Sequencing Test2 710 NPHS2 (Podocin) Sequencing Analysis 14607(X) FISH, X-Linked Ichthyosis Steroid Sulfatase Deficiency3 91566 SHOX (GHD) DNA Sequencing and Deletion Test3 678 Osmolality, Random Urine 823 GCK (CH) DNA Sequencing Test2 662 SOS1 DNA Sequencing Test2 677 Osmolality, Serum 866 GH1 (GHD) DNA Sequencing Test2 358 TACR3 DNA Sequencing Test2 16846 Plasma Renin Activity, LC/MS/MS 867 GHR DNA Sequencing Test2 712 TRPC6 DNA Sequencing Test2 718 PLCE1 DNA Sequencing Test2 868 GHRHR (GHD) DNA Sequencing Test2 959 Tryptophan, LC/MS 712 TRPC6 DNA Sequencing Test2 822 GLUD1 (CH) DNA Sequencing Test2 902 Tyrosine 713 WT1 DNA Sequencing Test2 Storage Disease Type 1a Mutation Analysis 858 Von Hippel-Lindau Syndrome (VHL) Evaluation2 Gonadal Function 90915 3 (Ashkenazi Jewish) 2 713 WT1 DNA Sequencing Test 8658(X) Alpha Subunit3 343 GnRH1 DNA Sequencing Test2 5276(X) 3α-Androstanediol Glucuronide (3-Alpha Diol G) 846 Noonan Syndrome (PTPN11) DNA Sequencing Test2 837 CEL (MODY8) Mutation Analysis2 17182 Androstenedione, LC/MS/MS 864 POU1F1 (CPHD) DNA Sequencing Test2 372 C-Peptide Anosmic Kallmann/IHH Evaluation2 746 Prolactin 4643(X) C-Peptide, 24-Hour Urine Detects mutations in FGF8, FGFR1, GnRHR, KAL1, KISS1R, PROK2, 462 2 and PROKR2. 863 PROP1 (CPHD) DNA Sequencing Test Diabetes, Advancing Management Panel 16842(X) Anti-Müllerian Hormone AssessR™1 91566 SHOX (GHD) DNA Sequencing and Deletion 91713(X) Includes electrolyte panel; microalbumin, random urine with creatinine; 2 662 SOS1 DNA Sequencing Test2 creatinine, serum; hemoglobin; PTH, intact and calcium; phosphate (as Complete Kallmann/IHH Evaluation phosphorus); QuestAssureD™ 25-hydroxyvitamin D (D2, D3), Detects mutations in CHD7, FGF8, FGFR1, GnRHR, GnRH1, KAL1, KISS1R, 679 LC/MS/MS. PROK2, PROKR2, and TACR3. 35167 T4, Free, Direct Dialysis DHEA (Dehydroepiandrosterone), Unconjugated, 866 T4, Free (Non-dialysis) Diabetes, Newly Diagnosed and Monitoring Panel 19894 91712(X) Includes glucose; hemoglobin A1c; lipid panel; hepatic function panel; LC/MS/MS 17733 T4, Total (Thyroxine) microalbumin, random urine with creatinine; creatinine, serum. 38954 DHEA (Dehydroepiandrosterone), Urine Hypothalamic and Pituitary Function Early Onset Obesity Evaluation2 884 Detects mutations in LEPR and MC4R. 402 DHEA Sulfate 211 ACTH, Plasma 883 Early Onset Obesity (LEPR) DNA Sequencing Test2 90567 Dihydrotestosterone, LC/MS/MS1 8658(X) Alpha Subunit1 2 1 3 Early Onset Obesity (MC4R) DNA Sequencing Test 36168 Dihydrotestosterone, Free, Serum 252(X) Arginine Vasopressin (AVP, Antidiuretic Hormone, ADH) 640 Detects mutations in MC4R. 2 36169 Estradiol, Free, LC/MS/MS Combined Pituitary Hormone Deficiency Evaluation 90393 Fat Malabsorption (Response to Vitamin D2 Supplement) 865 Detects mutations in POU1F1 and PROP1. 30289 Estradiol, Ultrasensitive, LC/MS/MS 8340 Fructosamine 470 FSH (Follicle Stimulating Hormone) 439 , Total, Serum 10584(X) GAD65, IA-2, and Insulin Autoantibody 36087 FSH (Follicle Stimulating Hormone), Pediatrics1 36742 , Fractionated, LC/MS/MS 478(X) Gastrin 7137 FSH and LH 23244 , LC/MS/MS 803 GCK (MODY2) DNA Sequencing and Deletion Test2 36176 FSH and LH, Pediatrics1 37104(X) 842 GCK (NDM) DNA Sequencing Test2 866 GH1 (GHD) DNA Sequencing Test2 470 FSH (Follicle Stimulating Hormone) 519 Glucagon1 1 521 Growth Hormone (GH) 36087 FSH (Follicle Stimulating Hormone), Pediatrics † Glucose 37072(X) Growth Hormone Antibody3 7137 FSH and LH 34878 Glutamic Acid Decarboxylase-65 Antibody 1 615 LH 36176 FSH and LH, Pediatrics 5032(X) Glycated Albumin 36086 LH, Pediatrics1 8396 hCG, Total, Quantitative Glycogen Storage Disease Type 1a Mutation Analysis 864 POU1F1 (CPHD) DNA Sequencing Test2 90915 19720 hCG, Total, with HAMA Treatment (Ashkenazi Jewish)1 746 Prolactin 29488(X) Glycohemoglobin, Total 36707(X) Hirsutism Panel 2 Includes androstenedione, DHEA sulfate, and free and total testosterone. 40049 Prolactin, Dilution Study 19599 GlycoMark® 8352 17-Hydroxypregnenolone, LC/MS/MS 16122 Prolactin, Total and Monomeric 496 Hemoglobin A1c 17180 17-Hydroxyprogesterone, LC/MS/MS 863 PROP1 (CPHD) DNA Sequencing Test2 Hemoglobin A1c with Calculated Mean Plasma Glucose 8181 17654(X) 17-Hydroxyprogesterone, Neonatal/Infant 34480 Somatostatin1 (MPG) 11303 Hyperglycosylated hCG (h-hCG) 899 TSH 16802 Hemoglobin A1c with eAG 34472 Inhibin A 36577 TSH Antibody1 16715 Hemoglobin A1c with Reflex to GlycoMark® 34445 Inhibin B1 19537 TSH with HAMA Treatment 5-HIAA (5-Hydroxyindoleacetic Acid), 24-Hour Urine, with 39625(X) 15201(X) 17-Ketosteroids with Creatinine, 24-Hour Urine Lipid Disorders Creatinine 4 5-HIAA (5-Hydroxyindoleacetic Acid), 24-Hour Urine, without 70184(X) 17-Ketosteroids, Fractionated, Pediatrics, Urine 15060(X) Adiponectin 523(X) Creatinine 4932(X) 17-Ketosteroids, Fractionated, Urine 893 ApoB Mutation Analysis2 1648(X) 5-HIAA (5-Hydroxyindoleacetic Acid), Random Urine 615 LH 5223(X) Apolipoprotein A1 802 HNF4A (MODY1) DNA Sequencing and Deletion Test2 36086 LH, Pediatrics1 5224(X) Apolipoprotein B 37054(Z) β-Hydroxybutyrate 17625(X) Male Infertility Genetic Analysis Apolipoprotein Evaluation 36177(X) IA-2 Antibody 2 7018(X) Includes apolipoprotein A1, apolipoprotein B, and apolipoprotein 817 Male Precocious Puberty (LHCGR) DNA Sequencing Test B/A1 ratio. 36590 IGF Binding Protein-1 (IGFBP-1)1 Normosmic Kallmann/IHH Evaluation2 2 Bardet-Biedl Syndrome Evaluation 1 667 Detects mutations in FGFR1, GnRH1, GnRHR, KISS1R, PROK2, PROKR2, 887 Detects mutations in BBS1, BBS2, and BBS10. 37102(X) IGF Binding Protein-2 (IGFBP-2) and TACR3. 886 BBS10 (BBS) DNA Sequencing Test2 34458 IGF Binding Protein-3 (IGFBP-3) 10328 Ovarian Antibody Screen with Reflex to Titer 1 90649 Cardio IQ™ ApoE Genotype1 16293 IGF-I, LC/MS 31493(X) Pregnenolone, LC/MS/MS 2 91604 Cardio IQ™ Lipoprotein Fractionation, Ion Mobility 853 INS (NDM) DNA Sequencing Test 17183 Progesterone, LC/MS/MS 334(X) Cholesterol, Total 561 Insulin 746 Prolactin 8293(X) Direct LDL 36178 Insulin Autoantibody 40049 Prolactin, Dilution Study Early Onset Obesity Evaluation2 36700 Insulin, Free (Bioactive) 16122 Prolactin, Total and Monomeric 884 Detects mutations in LEPR and MC4R. 91083 Insulin, LC/MS/MS1 30740 Sex Hormone Binding Globulin 2 883 Early Onset Obesity (LEPR) DNA Sequencing Test 834 IPF1 (MODY4) DNA Sequencing Test2 Steroid Panel, PCOS/CAH Differentiation 2 Early Onset Obesity (MC4R) DNA Sequencing Test 841 IPF1 (NDM) DNA Sequencing Test2 90426 Includes androstenedione, 11-deoxycortisol, DHEA, 640 Detects mutations in MC4R. 17-hydroxyprogesterone, and free and total testosterone. 36741 Islet Cell Antibody Screen with Reflex to Titer2 90393 Fat Malabsorption (Response to Vitamin D2 Supplement) 90424 Steroid Panel, Polycystic Syndrome (PCOS) 843 KCNJ11 (NDM) DNA Sequencing Test2 Includes androstenedione, DHEA, and total and free testosterone. 608(X) HDL Cholesterol 90367 Leptin3 Steroid Panel, Premature Adrenarche 35932(X) HDL Cholesterol Subclasses 90433 Includes androstenedione, DHEA, 17-hydroxypregnenolone, Metabolic Syndrome and Glucose Control Including Insulin 17-hydroxyprogesterone, and total testosterone. 31789 Homocysteine (Cardiovascular) 91398 Includes cholesterol, total and HDL; glucose; insulin, LC/MS/MS; 2 triglycerides; and calculated components. 14966 Testosterone, Free, Bioavailable, and Total, LC/MS/MS 895 Hypercholesterolemia Evaluation Detects mutations in LDLR and disease-associated regions of ApoB. 15281 Microalbumin, 24-Hour Urine (with Creatinine) 15983 Testosterone, Total, LC/MS/MS 2 894 LDLR (Hypercholesterolemia) DNA Sequencing Test 4555 Microalbumin, 24-Hour Urine (without Creatinine) 19958 Testosterone, Total (Males), Immunoassay 1 90367 6517 Microalbumin, Random Urine (with Creatinine) Testosterone, Total and Free and Sex Hormone 37073 Lipid Panel Binding Globulin 17674 Microalbumin, Random Urine (without Creatinine) 7600(X) Includes HDL and total cholesterol, triglycerides, and calculated Growth and Growth Hormone components (LDL-cholesterol, cholesterol:HDL-cholesterol ratio, and Monogenic Diabetes (MODY) Evaluation2 non-HDL cholesterol). 885 Includes sequencing and deletion detection in GCK, HNF4A, TCF1, and Combined Pituitary Hormone Deficiency Evaluation2 TCF2 and sequencing of IPF1. 865 Detects mutations in POU1F1 and PROP1. Lipid Panel w/Reflex to Direct LDL 14852(X) Includes cholesterol, HDL, cholesterol/HDL ratio, LDL (calculated), 2 882 Neonatal Diabetes Mellitus Evaluation 866 GH1 (GHD) DNA Sequencing Test2 and triglycerides. Detects mutations in ABCC8, GCK, INS, IPF1, and KCNJ11. 867 GHR DNA Sequencing Test2 34604(X) Lipoprotein(a) 449(X) Nonesterified Fatty Acids (Free Fatty Acids) 868 GHRHR (GHD) DNA Sequencing Test2 449(X) Nonesterified Fatty Acids (Free Fatty Acids) 678 Osmolality, Random Urine 521 Growth Hormone (GH) 91001 Omega-3 and -6 Fatty Acids, Plasma 677 Osmolality, Serum 37072(X) Growth Hormone Antibody3 717 Phospholipids4 4789(X) Pancreatic Polypeptide3 Growth Hormone Deficiency Evaluation 896 Triglycerides 760(X) Proinsulin4 848 Includes sequencing and deletion detection in SHOX and sequencing 90559 Very Long Chain Fatty Acids QuestAssureD™ 25-Hydroxyvitamin D (D2, D3), of GH1 and GHRHR. 17306 LC/MS/MS † Growth Hormone, Multiple Specimens Metabolic (Including Diabetes Mellitus) and Gastrointestinal Disorders 2 QuestAssureD™ for Infants, 25-Hydroxyvitamin D, 1 876 ABCC8 (NDM) DNA Sequencing Test 91935 16293 IGF-I, LC/MS LC/MS/MS 4 1 15060(X) Adiponectin 36590 IGF Binding Protein-1 (IGFBP-1) QuestAssureD™ 25-Hydroxy and 1,25-Dihydroxyvitamin 2 16761 37102(X) IGF Binding Protein-2 (IGFBP-2)1 Bardet-Biedl Syndrome Evaluation D, LC/MS/MS 887 Detects mutations in BBS1, BBS2, and BBS10. 34458 IGF Binding Protein-3 (IGFBP-3) 34480 Somatostatin1 886 BBS10 (BBS) DNA Sequencing Test2 658 KRAS/RAF1/SOS1 DNA Sequencing Evaluation2 818(X) Serotonin, Blood 825 CASR DNA Sequencing Test2 804 TCF1 (MODY3) DNA Sequencing and Deletion Test2 7573 Iron, Total and Total Iron binding Capacity 870 TBG (Thyroxine Binding Globulin) 805 TCF2 (MODY5) DNA Sequencing and Deletion Test2 90367 Leptin1 Thyroid Cascading Reflex Initial TSH results will determine further reflex orders of Free T4, TPO 1 15102(X) 920(X) Vasoactive Intestinal Polypeptide (VIP) Lipid Panel antibodies, and Free T3. 7600(X) Includes HDL and total cholesterol, and triglycerides; calculated 90559 Very Long Chain Fatty Acids components include LDL-cholesterol, chol/HDL ratio, and 899 TSH non-HDL cholesterol. 16558 , 1,25-Dihydroxy, LC/MS/MS 36577 TSH Antibody1 34604(X) Lipoprotein(a) Multiple Endocrine Neoplasia 90896 TSH, QuestAssureD™ 25-Hydroxyvitamin D (D2, D3), 211 ACTH, Plasma 17306 LC/MS/MS 19537 TSH with HAMA Treatment 30742(X) 90353 Vitamin B1 (Thiamine), LC/MS/MS 36127(X) TSH with Reflex to Free T4 303 Calcium Parathyroid and 30551 TSI (Thyroid Stimulating Immunoglobulin) 1635(X) Calcium, 24-Hour Urine (with Creatinine) 29498 Alkaline Phosphatase, Specific Selective Sampling-Petrosal Sinus and Adrenal Vein Sampling 306 Calcium, Ionized 231 Alkaline Phosphatase Isoenzymes 211 ACTH, Plasma 11216(X) Calcium, Pediatric Urine (with Creatinine) Autoimmune Polyglandular Syndrome (AIRE) Evaluation2 18821 Aldosterone/Cortisol Ratio, 2 Sites 1633(X) Calcium, Random Urine (with Creatinine) 812 Detects point mutations, deletions, insertions, and rearrangements 18822 Aldosterone/Cortisol Ratio, 3 Sites in AIRE. 39627(X) Catecholamines, Fractionated, 24-Hour Urine 18823 Aldosterone/Cortisol Ratio, 4 Sites 30742(X) Calcitonin 314(X) Catecholamines, Fractionated, Plasma 18825 Aldosterone/Cortisol Ratio, 5 Sites Collagen Cross-Linked N-Telopeptide (NTx), 36167(X) 5244 Catecholamines, Fractionated, Random Urine 2-Hour Urine or Second AM Void 18826 Aldosterone/Cortisol Ratio, 6 Sites 16381 Catecholamines, Fractionated, Supine, Plasma Collagen Cross-Linked N-Telopeptide (NTx), 18827 Aldosterone/Cortisol Ratio, 7 Sites 36421 16382 Catecholamines, Fractionated, Upright, Plasma 24-Hour Urine 18824 Aldosterone/Cortisol Ratio, 8 Sites 39626(X) Catecholamines, Fractionated, and VMA, 24-Hour Urine 17406 Collagen Type I C-Telopeptide (CTx) 19573(X) Aldosterone/Cortisol Ratio, Adrenal Vein Sampling 1 Familial Hypocalciuric Hypercalcemia (CASR) DNA 16379 Chromogranin A, Electrochemiluminescence 829 Aldosterone/Cortisol Ratio, Adrenal Vein Sampling Sequencing Test2 18818 372 C-Peptide 3 Sites 91001 Omega-3 and -6 Fatty Acids, Plasma Aldosterone/Cortisol Ratio, Adrenal Vein Sampling 4643(X) C-Peptide, 24-Hour Urine 18819 16322 Osteocalcin, N-MID 5 Sites 478(X) Gastrin 16609 Procollagen Type I Intact N Terminal Propeptide 519 Glucagon1 36578 PTH Antibody1 90477 BRAF Mutation Analysis, Papillary Thyroid Cancer1 521 Growth Hormone (GH) 36736 PTH, Intact (ICMA) and Ionized Calcium 30742(X) Calcitonin 39625(X) 5-HIAA (5-Hydroxyindoleacetic Acid), 24-Hour Urine 8837 PTH, Intact and Calcium 978(X) (CEA) 1648(X) 5-HIAA (5-Hydroxyindoleacetic Acid), Random Urine 16560 PTH, Intact, Fine Needle Aspirate 15018 CEA with HAMA Treatment 39527(X) Homovanillic Acid, 24-Hour Urine 34478(X) PTH-Related Protein (PTH-RP)4 90474 PAX8/PPAR[gamma] Translocation, Thyroid Cancer1 6346 Homovanillic Acid, Random Urine QuestAssureD™ 25-Hydroxyvitamin D (D2, D3), 90479 RAS Mutation Analysis, Thyroid Cancer1 561 Insulin 17306 LC/MS/MS 90473 RET/PTC Rearrangement, Thyroid Cancer1 36700 Insulin, Free (Bioactive) QuestAssureD™ for Infants, 25-Hydroxyvitamin D, 91935 267 Thyroglobulin Antibody 91083 Insulin, LC/MS/MS1 LC/MS/MS Thyroglobulin Panel 36587(X) MEN2 and FMTC Mutations, Exons 10, 11, 13-161 QuestAssureD™ 25-Hydroxy and 1,25-Dihydroxyvitamin D, 30278 16761 Includes thyroglobulin and thyroglobulin antibody. LC/MS/MS 14962(X) Metanephrines, Fractionated, LC/MS/MS, 24-Hour Urine Thyroglobulin Panel with HAMA Treatment 16558 Vitamin D, 1,25-Dihydroxy, LC/MS/MS 19584 Includes thyroglobulin, pre and post HAMA precipitation, and 19548 Metanephrines, Fractionated, Free, LC/MS/MS, Plasma thyroglobulin antibody. Pituitary Tumors 14961(X) Metanephrines, Fractionated, LC/MS/MS, Random Urine 16559 Thyroglobulin, Fine Needle Aspirate 3 211 ACTH, Plasma 4789(X) Pancreatic Polypeptide Thyroid Cancer Monitoring1 1 Pheochromocytoma Evaluation2 8658(X) Alpha Subunit Includes a thyroglobulin antibody test. If positive, reflexes to thyroglobulin 889 90814 measurement using LC/MS/MS. If negative, reflexes to thyroglobulin Detects mutations in RET, SDHB, and VHL. 3 252(X) Arginine Vasopressin (AVP, Antidiuretic Hormone, ADH) measurement using a highly sensitive immunoassay. 4 760(X) Proinsulin 1 16379 Chromogranin A, Electrochemiluminescence Thyroid Cancer Mutation Panel 90469 1 746 Prolactin 37077(X) Cortisol, Free and Total, LC/MS/MS (BRAF, RAS, RET/PTC, PAX8/PPAR) 40049 Prolactin, Dilution Study 36423(X) Cortisol, Free, LC/MS/MS 90819 Thyroid FNA Cytomorphology Evaluation 16122 Prolactin, Total and Monomeric 11280(X) Cortisol, Free, LC/MS/MS, 24-Hour Urine 90818 Thyroid FNA Cytomorphology with Molecular Reflex 36736 PTH, Intact (ICMA) and Ionized Calcium 90582 Cortisol, Free, LC/MS/MS, Second Void Urine Thyroid Function See above for thyroid cancer. 8837 PTH, Intact and Calcium 19897(X) Cortisol, LC/MS/MS, Saliva 30742(X) Calcitonin 1 16560 PTH, Intact, Fine Needle Aspirate 11281(X) Cortisol, Total, LC/MS/MS 16053(X) Resistance to Thyroid Hormone (RTH) Mutation Analysis 1 34478(X) PTH-Related Protein (PTH-RP) 470 FSH (Follicle Stimulating Hormone) 90963 T3, Reverse, LC/MS/MS 1 818(X) Serotonin, Blood 36087 FSH (Follicle Stimulating Hormone), Pediatrics1 36574 T3 (Triiodothyronine) Antibody 29851 Serotonin, Serum FSH (Follicle Stimulating Hormone), 34429 T3, Free, Non-Dialysis 14570 920(X) Vasoactive Intestinal Polypeptide (VIP)1 Timed (5 Samples), Pediatrics1 36598 T3, Free, Tracer Dialysis 39517(X) VMA, 24-Hour Urine 7137 FSH and LH 859 T3, Total 1710 VMA (Vanillylmandelic Acid), Random Urine 36176 FSH and LH, Pediatrics1 17732(X) T3, Uptake Neuroendocrine Markers 521 Growth Hormone (GH) 36576 T4, (Thyroxine) Antibody1 16379 Chromogranin A, Electrochemiluminescence1 37072(X) Growth Hormone Antibody3 35167 T4, Free, Direct Dialysis 39625(X) 5-HIAA (5-Hydroxyindoleacetic Acid), 24-Hour Urine 34458 IGF Binding Protein-3 (IGFBP-3) 866 T4, Free (Non-dialysis) 1648(X) 5-HIAA (5-Hydroxyindoleacetic Acid), Random Urine 16293 IGF-I, LC/MS1 17733 T4, Total (Thyroxine) 39527(X) Homovanillic Acid, 24-Hour Urine 615 LH 870 TBG (Thyroxine Binding Globulin) 6346 Homovanillic Acid, Random Urine 36086 LH, Pediatrics1 5738 TBII (Thyrotropin-Binding Inhibitory Immunoglobulin) 39517(X) VMA, 24-Hour Urine 746 Prolactin 267 Thyroglobulin Antibody 1710 VMA (Vanillylmandelic Acid), Random Urine 40049 Prolactin, Dilution Study Thyroglobulin Panel 30278 Includes thyroglobulin and thyroglobulin antibody. 920(X) Vasoactive Intestinal Polypeptide (VIP)1 16122 Prolactin, Total and Monomeric

1 1 Thyroglobulin Panel with HAMA Treatment 34480 Somatostatin 34480 Somatostatin 19584 Includes thyroglobulin, pre and post HAMA precipitation, and Obesity and Post-Obesity 899 TSH thyroglobulin antibody. 15060(X) Adiponectin4 36577 TSH Antibody1 Thyroid Cascading Reflex 15102(X) Initial TSH results will determine further reflex orders of Free T4, TPO Bardet-Biedl Syndrome Evaluation2 19537 TSH with HAMA Treatment antibodies, and Free T3. 887 Detects mutations in BBS1, BBS2, and BBS10. Resistance to Thyroid Hormone 7260(X) Thyroid Peroxidase and Thyroglobulin Antibodies 886 BBS10 (BBS) DNA Sequencing Test2 8658(X) Alpha Subunit1 5081 Thyroid Peroxidase Antibody (Anti-TPO) 90649 Cardio IQ™ ApoE Genotype1 16053(X) Resistance to Thyroid Hormone (RTH) Mutation Analysis1 899 TSH 91604 Cardio IQ™ Lipoprotein Fractionation, Ion Mobility 36598 T3, Free, Tracer Dialysis 36577 TSH Antibody1 Early Onset Obesity Evaluation2 884 Detects mutations in LEPR and MC4R. 859 T3, Total 90896 TSH, Pregnancy 883 Early Onset Obesity (LEPR) DNA Sequencing Test2 36574 T3 (Triiodothyronine) Antibody 19537 TSH with HAMA Treatment 1 2 36576 T4 (Thyroxine) Antibody 36127(X) TSH with Reflex to Free T4 640 Early Onset Obesity (MC4R) DNA Sequencing Test Detects mutations in MC4R. 35167 T4, Free, Direct Dialysis 30551 TSI (Thyroid Stimulating Immunoglobulin) 457 Ferritin 866 T4, Free (Non-dialysis) 467(X) Folate, RBC 17733 T4, Total (Thyroxine) 466 Folate, Serum 5738 TBII (Thyrotropin-Binding Inhibitory Immunoglobulin) QuestDiagnostics.com Quest, Quest Diagnostics, AssessR, Cardio IQ, QuestAssureD, XSense, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third party marks - ® and ™ - are the property of their respective owners. © 2014 Quest Diagnostics Incorporated. All rights reserved. TL3670 02/2014